Navigation Links
Go Healthy Initiates Additional Clinical Tests on Cholesterade
Date:5/8/2008

HOUSTON, May 8 /PRNewswire-FirstCall/ -- Go Healthy (Pink Sheets: GOHE) announces the initiation of further clinical trials with Cholesterade (R) in three medical settings with an expected patient clinical group of 200 patients in 6 centers around the country. Dr. William Bryan of the Sports Medicine Institute at The Methodist Hospital in the Texas Medical Center will coordinate one clinical trial. Dr. Bryan was formerly the Team Physician for the Houston Astros and the former Medical Director of Major League Baseball.

Dr. David Braunreiter of Memorial Hermann Hospital, the Team Physician for the Houston Dynamo and the NFL's Houston Texans will coordinate a center in Southwest Houston. Dr. Jason Pirozzolo of the Sports Medicine Institute at the Florida Hospital in Orlando will coordinate a third center, pending IRB approval. Pirozzolo recently completed Sports Medicine fellowships at the Ohio State University and Duke University.

Future centers will be coordinated by CO-PIs, Dr. Hal Goforth, widely acclaimed researcher on muscle glycogen metabolism from Point Loma Nazarene University and the Naval Research Center, and Dr. Fran Pirozzolo, Chairman of the Medical and Scientific Advisory Board of Go Healthy. Dr. Fran Pirozzolo was formerly the Chief of the Neuropsychology Service in the Department of Neurology at the Baylor College of Medicine. He was a Member of the National Academy of Sciences Committee on Techniques to Enhance Human Performance and has served on a number of NIH and NIMH advisory committees.

The study will be a double-blind crossover study of the efficacy of Cholesterade(R) in lowering cholesterol (total cholesterol and LDL) and triglycerides while increasing HDL and HDLC/LDLC ratio. The study will also employ a modified Experience Sampling Technique to measure the vitality of subjects throughout the day.

Charlie Caudle, CEO of Go Healthy, states that "We are very excited to be moving forward on studies that will expand on Dr. Cade's work and which we believe will conclusively demonstrate that Cholesterade(R) will bring a dramatic, meaningful contribution to the improvement of health in the cholesterol and other areas, including obesity and diabetes. This delicious drink will now allow the medical community to provide a compliance vehicle to meet NIH guidelines for 10-25 grams of dietary soluble fiber during a 12 week period of Therapeutic Lifestyle Changes prior to consideration of statin intervention. Subsequent studies we are planning will delve into those other areas and demonstrate the vital importance of dietary soluble fiber in general wellness."

Forward-Looking Statements Disclosure

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risks, and uncertainties, and by reference to the underlying assumptions.

Contact:

Charlie Caudle

CEO - Go Healthy, Inc.

(888) 282-7256

Brokers and Analysts call

Aero Financial, Inc

972-265-7590


'/>"/>
SOURCE Go Healthy, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine
3. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
4. Folate in Strawberries May Contribute to Healthy Pregnancy
5. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
6. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
10. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
11. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):